IGF1 and Hyperinsulinemia: Although the pathways by which the metabolic syndrome and its components increase cancer risk have not been fully elucidated, likely mechanisms involve insulin resistance, hyperinsulinemia, and elevated levels of insulin-like growth factor (IGF)-1, as well as increased levels of inflammation [17].